Nuclear Medicine and Biology
Volume 36, Issue 4 , Pages 363-369, May 2009

Radiolabeling of trastuzumab with 177Lu via DOTA, a new radiopharmaceutical for radioimmunotherapy of breast cancer

  • Samira Rasaneh

      Affiliations

    • Department of Medical Physics, Tarbiat Modares University, Tehran, Iran
    • ,
  • Hossein Rajabi

      Affiliations

    • Department of Medical Physics, Tarbiat Modares University, Tehran, Iran
    • Corresponding Author InformationCorresponding author. Tel.: +98 21 82883894; fax: +98 21 88006544.
    • ,
  • Mohammad Hossein Babaei

      Affiliations

    • Department of Radioisotope, Nuclear Science and Technology Research Institute, Tehran, Iran
    • ,
  • Fariba Johari Daha

      Affiliations

    • Department of Radioisotope, Nuclear Science and Technology Research Institute, Tehran, Iran
    • ,
  • Mojtaba Salouti

      Affiliations

    • Department of Biology, School of Sciences, Islamic Azad University - Zanjan Branch, Zanjan, Iran

Received 20 October 2008; received in revised form 18 January 2009; accepted 31 January 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0969-8051(09)00039-0

doi:10.1016/j.nucmedbio.2009.01.015

Nuclear Medicine and Biology
Volume 36, Issue 4 , Pages 363-369, May 2009

Article Tools

* Image Usage & Resolution